A family sold their townhouse in Bradford, Ont., about 70 kilometres north of downtown Toronto, and set themselves a ...

Vercel has released Next.js 16.2, featuring performance enhancements that make development startup 400% faster and rendering ...

Mikel Arteta has some huge decision to make with his team selection for the Champions League final (Picture: Getty) Mikel ...

Jurrien Timber is fit and available to start in Arsenal’s Champions League final against Paris Saint-Germain. The Netherlands ...

Texans QB C.J. Stroud is only focused on improving in 2026 following a catastrophic end to last season, but he also maintains his belief that he's earned a contract extension in Houston.

Arne Slot has turned down the chance to take charge of Ajax and wants to continue as the manager of Liverpool, according to a reliable Dutch journalist. Slot was appointed the Liverpool manager in the ...

Trials of the British Army’s Ajax armoured vehicles are set to resume, despite major delays amid concern for soldiers’ safety. Minister for Defence Readiness and Industry Luke Pollard announced in ...

Trials of the British Army's Ajax armoured vehicle will be "proceeding cautiously" after they were halted last year, a defence minister has said. A decision was made to stop using the Ajax after ...

Add Yahoo as a preferred source to see more of our stories on Google. Colonel Hamish de Bretton Gordon, late of the Royal Tank Regiment, prepares to test drive the Ajax for the Telegraph The most ...

Eli Lilly LLY-0.02%decrease; red down pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...